Haemophilia Care in India: A Multicentre Cross-Sectional Analysis From the World Bleeding Disorders Registry Benchmarking Across Global Gross National Income Strata [0.03%]
印度血友病护理的现状：来自世界出血性疾病登记中心多中心横断面分析及全球国民总收入分层评估
Nita Radhakrishnan,M Joseph John,Emily Ayoub et al.
Nita Radhakrishnan et al.
Background: Haemophilia care varies across economic settings, influencing diagnosis, treatment and outcomes. The World Bleeding Disorders Registry (WBDR) enables standardized, patient-level global benchmarking. We present...
The Relationship Between Y-90 and Bleeding Frequency in Haemophilic Synovitis of the Knee: A Systematic Review [0.03%]
Y-90与膝关节血友病性滑膜炎出血频率关系的系统评价
Aaron Ray,Matthew Steel,Emma L Rowbotham
Aaron Ray
Background: Haemophilic synovitis secondary to joint bleeding predisposes to recurrent episodes of haemarthrosis and the development of haemophilic arthropathy (HA). The knee is the most common large joint involved. Knee ...
Ten-Year Trends in Haemophilia A Care in the East Mediterranean Region: Insights From WFH Annual Global Surveys (2014-2023) [0.03%]
东地中海地区血友病A护理十年趋势（2014-2023年世界血友病联盟年度全球调查结果）
Abdulrahman Algarni
Abdulrahman Algarni
Background: Haemophilia A (HA) is a single-gene disorder with significant regional variation in prevalence and case ascertainment across the world. This study estimates the trends in its prevalence, regional variation and...
A Psychometric Analysis of the Haemophilia Quality of Life Questionnaire for Adults Physical Health Subscale and Total Scores: Data From the Phase 3 XTEND-1 Trial in Patients With Severe Haemophilia A [0.03%]
成人血友病生活质量问卷体质健康亚量表和总分的测验计量学分析：来自严重甲型血友病患者XTEND-1三期试验的数据
Jérôme Msihid,Alfonso Iorio,Amanda Wilson et al.
Jérôme Msihid et al.
Introduction: Bleeding episodes can impair physical functioning and cause chronic pain in haemophilia A. The Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL) was administered in XTEND-1; the Physical Heal...
Inherited Bleeding Disorders in Pregnancy: Obstetric Management and Outcomes From a Tertiary Care Centre [0.03%]
三级医疗中心妊娠期遗传性出血障碍的产科处理及结局
Melis Altug Inan,Bilge Kapudere,Hanne Bulat Cim et al.
Melis Altug Inan et al.
Objective: This study aimed to evaluate the obstetric management, complications and clinical characteristics of pregnant women diagnosed with hereditary coagulation factor deficiencies at a tertiary obstetric centre over ...
Circulating and Synovial Fluid Levels of YKL-40 Protein in Patients With Severe Haemophilia A: Preliminary Observations [0.03%]
血友病A患者循环及滑液YKL-40蛋白水平的初步观察
Aikaterini Michalopoulou,Aimilia Mantzou,Anna Kouramba et al.
Aikaterini Michalopoulou et al.
Factors Influencing Sport-Induced Bleeding in Patients With Haemophilia Without Inhibitors: A Single Centre Retrospective Study of People Born in the 2000s [0.03%]
无抑制剂血友病患者运动相关出血的影响因素——2000年后出生的血友病患者的单中心回顾性研究
Rie Shirayama,Takuma Ito,Tetsuji Sato et al.
Rie Shirayama et al.
Introduction: Recent advances in prophylaxis with clotting factor concentrates have enabled people with haemophilia (PwH) to participate in high-intensity exercises; however, this does not preclude them from sports-induce...
Timely Diagnosis and Management in Adult Patients With Ehlers-Danlos Syndrome Experiencing Gynaecological Bleeding [0.03%]
成人Ehlers-Danlos综合征患者的妇科出血的及时诊断和管理
Amanda M Henderson,Haowei Sun
Amanda M Henderson
Genotype-Phenotype Correlation of Hereditary Plasminogen Deficiency: Molecular Mechanisms From 18 Patients With Cerebral Infarction [0.03%]
遗传性纤溶酶原缺乏的基因型与表型的相关性：来自18例脑梗死患者的分子机制研究
Yifan Lu,Haixiao Xie,Dandan Yu et al.
Yifan Lu et al.
Introduction: Hereditary plasminogen (PLG) deficiency is a rare congenital fibrinolytic disorder and a rare disease. This study conducted gene sequencing and statistical analysis on patients with cerebral infarction (CI) ...
Factor II and Factor V Deficiencies: Current Management, Care Gaps and Call to Action for Therapeutic Advances [0.03%]
第2因子和第5因子缺乏症：目前的管理方法、护理缺口及对治疗进展的呼吁
Samantha Pasca,Massimo Franchini,Pier Mannuccio Mannucci
Samantha Pasca
Introduction: Among rare inherited coagulation disorders (RICDs), prothrombin (factor II) and factor V (FV) deficiency are still orphans of treatments, lacking availability of single-factor replacement products. This clin...